|
Diethylstilboestrol (DES) is a synthetic form of oestrogen. It was prescribed between 1938 and 1971 to women as a means of ensuring a healthy pregnancy and preventing miscarriages.
Use of DES declined in the 1960s after studies showed that it was not effective in preventing pregnancy complications. When given during the first 5 months of a pregnancy, DES could interfere with the development of the reproductive system in a foetus, so any women and their children who were exposed to the drug, need special health care and monitoring.
Follow the links below to find information about DES.
Created November 2006
Printer friendly page
| Results 1 to 4 displayed. |
| Title: |
DES daughters - possible problems
|
| Publisher: |
Better Health Channel
|
| Description: |
Diethylstilboestrol, or DES, was prescribed in Australia as an anti-miscarriage drug between 1946 and 1971. Anyone who was exposed to DES needs special medical care because this drug can cause reproductive changes and diseases in both the mothers and their children.
|
| Date: |
Nov 2007
|
| Title: |
DES daughters - gynaecological changes
|
| Publisher: |
Better Health Channel
|
| Description: |
Women who were exposed to the drug diethylstilboestrol (DES) while in the womb can experience changes to their reproductive organs. Some of these changes can be misdiagnosed as other gynaecological conditions. It is recommended that all DES daughters have regular DES examinations.
|
| Date: |
Nov 2007
|
| Title: |
DES daughters - fertility and pregnancy
|
| Publisher: |
Better Health Channel
|
| Description: |
Exposure to the anti-miscarriage drug, diethylstilboestrol (DES) while in the womb can cause reproductive changes and fertility problems later in life. DES daughters also have a higher risk of ectopic pregnancy, miscarriage and premature labour.
|
| Date: |
Jun 2007
|
| Title: |
Vaginal cancer
|
| Publisher: |
Better Health Channel
|
| Description: |
Vaginal cancer is one of the rarest gynaecological cancers. The most commonly affected groups are women aged over 50 years, and women who were exposed in utero to the drug diethylstilbestrol (DES).
|
| Date: |
May 2007
|
| Results 1 to 4 displayed. |
|
